Definitive Contract HHSO100200600011C
Award Date
5/1/06
Potential Completion Date
4/30/15
Potential Value
$73M
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
MIDDLE CITY EAST, PA 19102, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
8
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $533,988.00 firm fixed price delivery order awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to the pharmaceutical company Glaxosmithkline, LLC. The contract is part of the Pandemic Influenza Preparedness and Response 2012-2016 IDIQ, which provides for the acquisition of medical countermeasures for pandemic influenza preparedness and response efforts. The contract does not have a set-aside designation....
This federal contract was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to the prime contractor Glaxosmithkline, LLC (doing business as Glaxosmithkline). The $977,025.74 fixed-price delivery order contract supports the Pandemic Influenza Preparedness and Response 2016-2021 program and is for the provision of pharmaceutical products and services related to disease prevention and treatment. Glaxosmithkline, a global...
This federal contract award establishes services for H5 pandemic readiness through the acquisition of medical countermeasures (MCMs) for pandemic influenza and emerging diseases preparedness and response. The contract, valued at $94,587,688.20, was awarded to the prime contractor Glaxosmithkline, LLC, a foreign-owned, for-profit pharmaceutical company. The contract is a delivery order issued under a larger Indefinite Delivery Contract (IDC) with the Department of Health and Human Services'...
This is a delivery order awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR) to GlaxoSmithKline, LLC, a pharmaceutical company, under the Pandemic Influenza Preparedness and Response 2012-2016 contract. The contract is for the production of non-GMP influenza vaccine plots at a firm fixed price of $149,412.00. The award supports ASPR's broader efforts for pandemic influenza preparedness and response, including disease...
This is a firm fixed price delivery order awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Glaxosmithkline, LLC, a pharmaceutical company, for the production of influenza vaccine master and working seed lots. The contract is part of the Pandemic Influenza Preparedness and Response 2012-2016 program and has a potential value of $533,988.00. There is no set-aside designation for this award. The contract supports the...
This is a firm fixed-price delivery order awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antivirals, and other pharmaceutical products to U.S. government agencies. The $15,769,590.00 contract is for commercial bulk lots, with no set-aside designation, and is part of the Pandemic Influenza Preparedness and Response 2016-2021 IDIQ contract. The...
This $563,504 firm fixed price delivery order was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The order is part of the Pandemic Influenza Preparedness and Response 2016-2021 indefinite delivery, indefinite quantity (IDIQ) contract and does not have a...
This is a firm fixed price delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Glaxosmithkline, LLC to provide the acquisition of egg-based influenza master and working seed lots derived from a specific candidate vaccine virus, as well as fill-finish of any existing egg-based influenza vaccines. The order has a ceiling value of $1,650,050.61 and a completion date of February 21, 2026. No set-aside designation was used....
This federal contract award, valued at $22,877,697.00, was issued by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS). The purpose of this Delivery Order is to procure an Influenza A/Astrakhan/3212/2020 (H5N8) virus vaccine candidate and conduct the associated clinical trial. This award was made to the prime contractor, Glaxosmithkline, LLC, a foreign-owned, for-profit pharmaceutical...
This is a $69,857,670.45 firm fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Glaxosmithkline, LLC, doing business as Glaxosmithkline, for 2016 pandemic influenza preparedness efforts. The contract has a completion date of February 28, 2017 and was awarded on December 18, 2015. There was no set-aside designation used. Glaxosmithkline is a pharmaceutical company that provides vaccines, antiviral medications, and other products to various federal agencies,...